EG
Eagle Pharmaceuticals, Inc.
EGRX · OTC
$0.18 +11.59% (+$0.02)
1M +143.40%
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/FCF N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
100 /100
Stable Beta 0.66x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EGRX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael Graves
Employees
135
Headquarters
Woodcliff Lake
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report